StonvexLoading…
StonvexStonvexStonvexCore line items from CTRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $2.98B | $2.64B | $2.90B | $2.76B |
Operating Income | $92.82M | $86.78M | $-77.56M | $-101.43M |
Net Income | $22.39M | $-6.72M | $-186.18M | $-168.15M |
EPS (Diluted) | $0.25 | $-0.08 | $-2.60 | $-2.35 |
Total Assets | $2.41B | $2.07B | $2.19B | Not available |
Total Liabilities | $1.53B | $1.51B | $1.86B | Not available |
Cash & Equivalents | $126.63M | $49.02M | $33.41M | $63.97M |
Free Cash Flow OCF − CapEx | $-8.20M | $58.90M | $60.81M | $-34.96M |
Shares Outstanding | 100.72M | 88.52M | 1.00K | 71.67M |